Medtronic plc is rated a Buy, expecting 10-11% annual total returns, supported by 7-8% EPS growth. Learn more about MDT stock ...

The stock's rise snapped a three-day losing streak.

Medtronic's fair value estimate has nudged higher to $111.05 from $109.82 as analysts grow more confident that the company ...

It is a well-established healthcare leader that generates consistent revenue and profits, with an impressive dividend track ...

Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

This was the stock's third consecutive day of losses.

Though the Medtronic OmniaSecure is the world's smallest defibrillation lead, the product development story isn't one of ...

Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

Symbiosis International University, through its Symbiosis Centre for Health Skills (SCHS), has partnered with Medtronic to ...

In Medtronic’s case specifically, the EY authors write, the company reported that its ability to predict and modulate supply ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...